Literature DB >> 19244568

Educating families on real time continuous glucose monitoring: the DirecNet navigator pilot study experience.

Laurel Messer1, Katrina Ruedy1, Dongyuan Xing1, Julie Coffey1, Kimberly Englert1, Kimberly Caswell1, Brett Ives1.   

Abstract

PURPOSE: The purpose of this article is to describe the process of educating families and children with type 1 diabetes on real time continuous glucose monitoring (RT-CGM) and to note the similarities and differences of training patients using continuous subcutaneous insulin infusion (CSII) versus multiple daily injections (MDI).
METHODS: A total of 30 CSII participants and 27 MDI participants were educated using the Navigator RT-CGM in a clinical trial. Time spent with families for visits and calls was tracked and compared between patient groups. The Diabetes Research in Children Network (DirecNet) educators were surveyed to assess the most crucial, time intensive, and difficult educational concepts related to CGM.
RESULTS: Of the 27 MDI families, an average of 9.6 hours was spent on protocol-prescribed visits and calls (not measured in CSII) and 2 hours on participant-initiated contacts over 3 months. MDI families required an average of 5.4 more phone contacts over 3 months than CSII families. According to the DirecNet educators, lag time and calibrations were the most crucial teaching concepts for successful RT-CGM use. The most time was spent on teaching technical aspects, troubleshooting, and insulin dosing. The most unanticipated difficulties were skin problems including irritation and the sensor not adhering well.
CONCLUSION: Educators who teach RT-CGM should emphasize lag time and calibration techniques, technical device training, and sensor insertion. Follow-up focus should include insulin dosing adjustments and skin issues. The time and effort required to introduce RT-CGM provided an opportunity for the diabetes educators to reemphasize good diabetes care practices and promote self-awareness and autonomy to patients and families.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19244568      PMCID: PMC3756565          DOI: 10.1177/0145721708325157

Source DB:  PubMed          Journal:  Diabetes Educ        ISSN: 0145-7217            Impact factor:   2.140


  11 in total

1.  A randomized multicenter trial comparing the GlucoWatch Biographer with standard glucose monitoring in children with type 1 diabetes.

Authors:  H Peter Chase; Roy Beck; William Tamborlane; Bruce Buckingham; Nelly Mauras; Eva Tsalikian; Tim Wysocki; Stuart Weinzimer; Craig Kollman; Katrina Ruedy; Dongyuan Xing
Journal:  Diabetes Care       Date:  2005-05       Impact factor: 19.112

2.  Continuous glucose monitoring in children with type 1 diabetes.

Authors:  Bruce Buckingham; Roy W Beck; William V Tamborlane; Dongyuan Xing; Craig Kollman; Rosanna Fiallo-Scharer; Nelly Mauras; Katrina J Ruedy; Michael Tansey; Stuart A Weinzimer; Tim Wysocki
Journal:  J Pediatr       Date:  2007-08-24       Impact factor: 4.406

3.  The accuracy of the FreeStyle Navigator continuous glucose monitoring system in children with type 1 diabetes.

Authors:  Darrell M Wilson; Roy W Beck; William V Tamborlane; Mariya J Dontchev; Craig Kollman; Peter Chase; Larry A Fox; Katrina J Ruedy; Eva Tsalikian; Stuart A Weinzimer
Journal:  Diabetes Care       Date:  2007-01       Impact factor: 19.112

4.  Accuracy of the modified Continuous Glucose Monitoring System (CGMS) sensor in an outpatient setting: results from a diabetes research in children network (DirecNet) study.

Authors:  Michael J Tansey; Roy W Beck; Bruce A Buckingham; Nelly Mauras; Rosanna Fiallo-Scharer; Dongyuan Xing; Craig Killman; William V Tamborlane; Katrina J Ruedy
Journal:  Diabetes Technol Ther       Date:  2005-02       Impact factor: 6.118

5.  Eight-point glucose testing versus the continuous glucose monitoring system in evaluation of glycemic control in type 1 diabetes.

Authors:  Rosanna Fiallo-Scharer
Journal:  J Clin Endocrinol Metab       Date:  2005-03-22       Impact factor: 5.958

6.  Timing of changes in interstitial and venous blood glucose measured with a continuous subcutaneous glucose sensor.

Authors:  Michael S Boyne; David M Silver; Joy Kaplan; Christopher D Saudek
Journal:  Diabetes       Date:  2003-11       Impact factor: 9.461

7.  Psychological aspects of continuous glucose monitoring in pediatric type 1 diabetes.

Authors: 
Journal:  Pediatr Diabetes       Date:  2006-02       Impact factor: 4.866

8.  FreeStyle navigator continuous glucose monitoring system use in children with type 1 diabetes using glargine-based multiple daily dose regimens: results of a pilot trial Diabetes Research in Children Network (DirecNet) Study Group.

Authors:  Stuart Weinzimer; Dongyuan Xing; Michael Tansey; Rosanna Fiallo-Scharer; Nelly Mauras; Tim Wysocki; Roy Beck; William Tamborlane; Katrina Ruedy
Journal:  Diabetes Care       Date:  2007-12-20       Impact factor: 19.112

9.  The accuracy of the GlucoWatch G2 biographer in children with type 1 diabetes: results of the diabetes research in children network (DirecNet) accuracy study.

Authors: 
Journal:  Diabetes Technol Ther       Date:  2003       Impact factor: 6.118

10.  Use of the DirecNet Applied Treatment Algorithm (DATA) for diabetes management with a real-time continuous glucose monitor (the FreeStyle Navigator).

Authors:  Bruce Buckingham; Dongyuan Xing; Stu Weinzimer; Rosanna Fiallo-Scharer; Craig Kollman; Nelly Mauras; Eva Tsalikian; William Tamborlane; Tim Wysocki; Katrina Ruedy; Roy Beck
Journal:  Pediatr Diabetes       Date:  2008-01-24       Impact factor: 4.866

View more
  16 in total

Review 1.  Hypoglycemia in critically ill children.

Authors:  E Vincent S Faustino; Eliotte L Hirshberg; Clifford W Bogue
Journal:  J Diabetes Sci Technol       Date:  2012-01-01

2.  Five-Month Follow-up Shows No Improvement in Dermatological Complications in Children With Type 1 Diabetes Using Continuous Glucose Monitoring Systems and Insulin Pumps.

Authors:  Anna T Weng; Claus Zachariae; Karl B Christensen; Jannet Svensson; Anna K Berg
Journal:  J Diabetes Sci Technol       Date:  2019-10-16

3.  Real-life utilization of real-time continuous glucose monitoring: the complete picture.

Authors:  Neesha Ramchandani; Sandeep Arya; Svetlana Ten; Sonal Bhandari
Journal:  J Diabetes Sci Technol       Date:  2011-07-01

4.  Analysis: high-tech diabetes technology and the myth of clinical "plug and play".

Authors:  Stuart A Weinzimer
Journal:  J Diabetes Sci Technol       Date:  2010-11-01

5.  Preserving Skin Integrity with Chronic Device Use in Diabetes.

Authors:  Laurel H Messer; Cari Berget; Christie Beatson; Sarit Polsky; Gregory P Forlenza
Journal:  Diabetes Technol Ther       Date:  2018-06       Impact factor: 6.118

6.  Glycaemic impact of patient-led use of sensor-guided pump therapy in type 1 diabetes: a randomised controlled trial.

Authors:  M A O'Connell; S Donath; D N O'Neal; P G Colman; G R Ambler; T W Jones; E A Davis; F J Cameron
Journal:  Diabetologia       Date:  2009-04-25       Impact factor: 10.122

Review 7.  Continuous glucose monitoring in type 1 diabetes.

Authors:  Nelly Mauras; Larry Fox; Kimberly Englert; Roy W Beck
Journal:  Endocrine       Date:  2012-08-28       Impact factor: 3.633

Review 8.  Influences on Technology Use and Efficacy in Type 1 Diabetes.

Authors:  Victoria Franklin
Journal:  J Diabetes Sci Technol       Date:  2016-05-03

Review 9.  Biopsychosocial Factors Associated With Satisfaction and Sustained Use of Artificial Pancreas Technology and Its Components: a Call to the Technology Field.

Authors:  Gregory P Forlenza; Laurel H Messer; Cari Berget; R Paul Wadwa; Kimberly A Driscoll
Journal:  Curr Diab Rep       Date:  2018-09-26       Impact factor: 4.810

10.  Effectiveness of continuous glucose monitoring in a clinical care environment: evidence from the Juvenile Diabetes Research Foundation continuous glucose monitoring (JDRF-CGM) trial.

Authors: 
Journal:  Diabetes Care       Date:  2009-10-16       Impact factor: 19.112

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.